Epistaxis resident survival guide

Revision as of 20:53, 10 August 2020 by Amir Bagheri (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Synonyms and keywords:

Overview

Epistaxis also known as noes bleeding, is a terminology name for bleeding of nose vessels that drains out from nostril (most often) and/or nasopharynx. Epistaxis is often stop easily but sometimes it's an ENT emergency which can be critical if appropriate action does not occur. Kiesselbach's plexus is the source of most epistaxis.

Causes

Base on the cause and severity of Epistaxis it can be life threatening.

Life Threatening Causes

Life-threatening causes of epistaxis include conditions that may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Diagnosis

Shown below is an algorithm summarizing the diagnosis of Epistaxis according the the [...] guidelines.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Treatment

Shown below is an algorithm summarizing the treatment of [[disease name]] according the the [...] guidelines.

StatementActionStrength

1:PromptmanagementAtthetimeofinitialcontact,theclinicianshoulddistinguishthenosebleedpatientwhorequirespromptmanagementfrom thepatientwhodoesnot.

Recommendation

2:NasalcompressionTheclinicianshouldtreatactivebleedingforpatientsinneedofpromptmanagementwithfirmsustainedcompressionto thelowerthirdofthenose,withorwithouttheassistanceofthepatientorcaregiver,for5minutesorlonger.

Recommendation

3a:NasalpackingForpatientsinwhombleedingprecludesidentificationofableedingsitedespitenasalcompression,theclinicianshould treatongoingactivebleedingwithnasalpacking.

Recommendation

3b:Nasalpackinginpatientswith suspectedincreasedbleedingrisk

Theclinicianshoulduseresorbablepackingforpatientswithasuspectedbleedingdisorderorforpatientswhoareusing anticoagulationorantiplateletmedications.

Recommendation

4:NasalpackingeducationTheclinicianshouldeducatethepatientwhoundergoesnasalpackingaboutthetypeofpackingplaced,timingofandplan forremovalofpacking(ifnotresorbable),postprocedurecare,andanysignsorsymptomsthatwouldwarrantprompt reassessment.

Recommendation

5:RiskfactorsTheclinicianshoulddocumentfactorsthatincreasethefrequencyorseverityofbleedingforanypatientwithanosebleed, includingpersonalorfamilyhistoryofbleedingdisorders,useofanticoagulantorantiplateletmedications,orintranasal druguse.

Recommendation

6:Anteriorrhinoscopytoidentify locationofbleeding

Theclinicianshouldperformanteriorrhinoscopytoidentifyasourceofbleedingafterremovalofanybloodclot(if present)forpatientswithnosebleeds.

Recommendation

7a:Examinationusingnasal endoscopy

Theclinicianshouldperform,orshouldrefertoaclinicianwhocanperform,nasalendoscopytoidentifythesiteof bleedingandguidefurthermanagementinpatientswithrecurrentnasalbleeding,despitepriortreatmentwithpackingor cautery,orwithrecurrentunilateralnasalbleeding.

Recommendation

7b:Examinationofnasalcavityand nasopharynxusingnasal endoscopy

Theclinicianmayperform,ormayrefertoaclinicianwhocanperform,nasalendoscopytoexaminethenasalcavityand nasopharynxinpatientswithepistaxisthatisdifficulttocontrolorwhenthereisconcernforunrecognizedpathology contributingtoepistaxis.

Option

8:Appropriateinterventionsfor identifiedbleedingsite

Theclinicianshouldtreatpatientswithanidentifiedsiteofbleedingwithanappropriateintervention,whichmayinclude oneormoreofthefollowing:topicalvasoconstrictors,nasalcautery,andmoisturizingorlubricatingagents.

Recommendation

9:NasalcauteryWhennasalcauteryischosenfortreatment,theclinicianshouldanesthetizethebleedingsiteandrestrictapplicationof cauteryonlytotheactiveorsuspectedsite(s)ofbleeding.

Recommendation

10:Ligationand/orembolizationfor persistentnosebleeds

Theclinicianshouldevaluate,orrefertoaclinicianwhocanevaluate,candidacyforsurgicalarterialligationorendovascular embolizationforpatientswithpersistentorrecurrentbleedingnotcontrolledbypackingornasalcauterization.

Recommendation

11:Managementofpatientsusing anticoagulationandantiplatelet medications

Intheabsenceoflife-threateningbleeding,theclinicianshouldinitiatefirst-linetreatmentspriortotransfusion,reversalof anticoagulation,orwithdrawalofanticoagulation/antiplateletmedicationsforpatientsusingthesemedications.

Recommendation

12:Hereditaryhemorrhagic telangiectasia(HHT)identification

Theclinicianshouldassess,orrefertoaspecialistwhocanassess,thepresenceofnasaltelangiectasiasand/ororalmucosal telangiectasiasinpatientswhohaveahistoryofrecurrentbilateralnosebleedsorafamilyhistoryofrecurrentnosebleeds todiagnosehereditaryhemorrhagictelangiectasiasyndrome.

Recommendation

13:Patienteducationand prevention

Theclinicianshouldeducatepatientswithnosebleedsandtheircaregiversaboutpreventivemeasuresfornosebleeds,home treatmentfornosebleeds,andindicationstoseekadditionalmedicalcare.

Recommendation

14:NosebleedoutcomesTheclinicianordesigneeshoulddocumenttheoutcomeofinterventionwithin30daysordocumenttransitionofcarein patientswhohadanosebleedtreatedwithnonresorbablepacking,surgery,orarterialligation/embolization.

Recommendation

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Do's

  • The content in this section is in bullet points.

Don'ts

  • The content in this section is in bullet points.

References


Template:WikiDoc Sources